课题基金 / 基金详情

Cochrane Complementary Medicine Field: Resource for Research

Cochrane Complementary Medicine Field: Resource for Research
Cochrane 补充医学领域:研究资源
批准号:
10538962
负责人:
BRIAN M BERMAN
金额:
$3.67万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2024-03-31

项目摘要

项目成果

BRIAN M BERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 Cochrane是一个国际非营利组织,其使命是改善与健康相关的 通过准备、维持和促进系统审查的可获得性来作出决定。这个 补充医学领域是Cochrane集团,专注于支持 Cochrane互补性和整体性系统评价的产生和传播 药物疗法。该领域的基础是一体化中心,并由其赞助 马里兰大学医学院,在布莱恩·伯曼的指导下,他是 1996年的《田野》。在过去的20年里,该领域一直通过24卢比的赠款得到支持 来自NCCIH的。外地利用这笔R24赠款显著推进了NCCIH的目标 发展和传播关于补充和综合健康的“当前最佳证据”,以 支持患者、卫生保健从业者、政策制定者和 研究管理员。然而,许多关于该技术的有效性和安全性的问题 补充疗法还没有相关的、最新的和可操作的答案,并且 有必要继续严格发展、有效传播和纳入 将补充和综合治疗的高质量、客观信息付诸实践。 为了进一步扩大补充医学领域作为研究资源,建议 我们的R24赠款续期有以下4个具体目标:1)改善和增加 补充医学干预对照试验数据库;2)增加 补充医学的高质量、高优先级、最新的系统评价;3) 提高补充医学领域的相关性、可用性和可及性 向患者、临床和研究利益相关者提供资源和研究证据;以及4)促进 通过为Cochrane组织做出贡献,开展国际合作。 自成立以来,该领域在我们的试验数据库中表现出了很高的生产力 开发、系统评审成果和方法论工作。外地将继续其 提高这些领域的生产效率,并提高ITS的有效优先顺序和知识转化 产品,由科克伦研究和传播基础设施和 外地在过去20年中建立了全球补充医学网络。
英文摘要
PROJECT SUMMARY Cochrane is an international nonprofit organization with the mission to improve health-related decisions by preparing, maintaining and promoting the accessibility of systematic reviews. The Complementary Medicine Field is the Cochrane group that is focused on supporting the production and dissemination of Cochrane systematic reviews of complementary and integrative medicine therapies. The Field is based within and sponsored by the Center for Integrative Medicine at the University of Maryland, under the direction of Brian Berman, who co-founded the Field in 1996. Over the past 20 years, the Field has been supported through an R24 grant from NCCIH. The Field has used this R24 grant to significantly advance NCCIH's objective to develop and disseminate the ‘current best evidence’ on complementary and integrative health to support decision-making on the part of patients, health care practitioners, policy makers, and research administrators. However, many questions about the usefulness and safety of complementary therapies do not yet have relevant, up-to-date, and actionable answers, and there is a need to continue the rigorous development, effective dissemination, and incorporation into practice of high quality, objective information on complementary and integrative therapies. To further expand the Complementary Medicine Field as a resource for research, this proposed renewal of our R24 grant has the following 4 specific aims: 1) Improve and increase the database of controlled trials of complementary medicine interventions; 2) Increase the number of high quality, high priority, up-to-date systematic reviews in complementary medicine; 3) Increase the relevance, usability and accessibility of the Complementary Medicine Field resources and research evidence to patient, clinical, and research stakeholders; and 4) Promote international collaboration by contributing to the Cochrane organization. Since its founding, the Field has displayed a high level of productivity in our trial database development, systematic review production, and methodological work. The Field will continue its productivity in these areas and increase effective prioritization and knowledge translation of its products, supported by the Cochrane research and dissemination infrastructure and the worldwide complementary medicine network developed by the Field over the previous 20 years.
期刊论文(209)
专著(0)
科研奖励(0)
会议论文
A Summary of a Cochrane Review: Ganoderma lucidum (Reishi mushroom) for the treatment of cancer.
Cochrane评论的摘要:用于治疗癌症的Ganoderma Lucidum(Reishi Mushroom)。
DOI: 10.1016/j.eujim.2016.07.025
发表时间: 2016-10
期刊: European journal of integrative medicine
影响因子: 2.5
作者: [Santesso N, Wieland LS]
通讯作者: Wieland LS
Vitamin D supplementation for the treatment of COVID-19: Summary of a living Cochrane review.
维生素D补充了Covid-19的治疗:生命Cochrane评论的摘要。
DOI: 10.1016/j.explore.2021.06.004
发表时间: 2021-09
期刊: Explore (New York, N.Y.)
影响因子: --
作者: [Wieland LS]
通讯作者: Wieland LS
DOI: 10.1016/j.ctim.2021.102746
发表时间: 2021-08
期刊: Complementary therapies in medicine
影响因子: 3.6
作者: [Wieland LS, Cramer H, Lauche R, Verstappen A, Parker EA, Pilkington K]
通讯作者: Pilkington K
Commentary on "Do Cochrane reviews reflect the latest evidence on meditation and mindfulness-based interventions? A snapshot of the current evidence".
关于“Cochrane 评论是否反映了冥想和正念干预的最新证据?当前证据的快照”的评论。
DOI: 10.1016/j.explore.2021.08.006
发表时间: 2021
期刊: Explore (New York, N.Y.)
影响因子: --
作者: [Wieland,LSusan]
通讯作者: Wieland,LSusan
共 142 条
    Cochrane Collaboration CAM Field: Resource for Research
    • 批准号:
      7569746
    • 项目类别:
    • 资助金额:
      $5.25万
    • 财政年份:
      2007
    • 负责人:
      BRIAN M BERMAN
    • 依托单位:
    Cochrane Collaboration CAM Field: Resource for Research
    • 批准号:
      7835486
    • 项目类别:
    • 资助金额:
      $47.51万
    • 财政年份:
      2007
    • 负责人:
      BRIAN M BERMAN
    • 依托单位:
    Cochrane Collaboration CAM Field: Resource for Research
    • 批准号:
      8068375
    • 项目类别:
    • 资助金额:
      $47.32万
    • 财政年份:
      2007
    • 负责人:
      BRIAN M BERMAN
    • 依托单位:
    Cochrane Collaboration CAM Field: Resource for Research
    • 批准号:
      7405989
    • 项目类别:
    • 资助金额:
      $40.46万
    • 财政年份:
      2007
    • 负责人:
      BRIAN M BERMAN
    • 依托单位:
    国内基金
    海外基金
    层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
    • 批准号:
      2021JJ40433
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
      孙磊
    • 依托单位:
    寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
    • 批准号:
      32001603
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      段真珍
    • 依托单位:
    AREA国际经济模型的移植.改进和应用
    • 批准号:
      18870435
    • 项目类别:
      面上项目
    • 资助金额:
      2.0万元
    • 批准年份:
      1988
    • 负责人:
      史树中
    • 依托单位: